Thrombocytosis in Patients with Pancreatic Cancer Treated with Gemcitabine
2012; Termedia Publishing House; Volume: 4; Linguagem: Inglês
10.5114/wo.2012.30068
ISSN1897-4309
AutoresAnna Świeboda-Sadlej, Leszek Kraj, Joanna Krawczyk, Ewa Nita, Jadwiga Dwilewicz‐Trojaczek,
Tópico(s)Inflammatory Biomarkers in Disease Prognosis
ResumoENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Świeboda-Sadlej A, Kraj L, Krawczyk J, Nita E, Dwilewicz-Trojaczek J. Thrombocytosis in Patients with Pancreatic Cancer Treated with Gemcitabine. Contemporary Oncology/Współczesna Onkologia. 2012;16(4):353-355. doi:10.5114/wo.2012.30068. APA Świeboda-Sadlej, A., Kraj, L., Krawczyk, J., Nita, E., & Dwilewicz-Trojaczek, J. (2012). Thrombocytosis in Patients with Pancreatic Cancer Treated with Gemcitabine. Contemporary Oncology/Współczesna Onkologia, 16(4), 353-355. https://doi.org/10.5114/wo.2012.30068 Chicago Świeboda-Sadlej, Anna, Leszek Kraj, Joanna Krawczyk, Ewa Nita, and Jadwiga Dwilewicz-Trojaczek. 2012. "Thrombocytosis in Patients with Pancreatic Cancer Treated with Gemcitabine". Contemporary Oncology/Współczesna Onkologia 16 (4): 353-355. doi:10.5114/wo.2012.30068. Harvard Świeboda-Sadlej, A., Kraj, L., Krawczyk, J., Nita, E., and Dwilewicz-Trojaczek, J. (2012). Thrombocytosis in Patients with Pancreatic Cancer Treated with Gemcitabine. Contemporary Oncology/Współczesna Onkologia, 16(4), pp.353-355. https://doi.org/10.5114/wo.2012.30068 MLA Świeboda-Sadlej, Anna et al. "Thrombocytosis in Patients with Pancreatic Cancer Treated with Gemcitabine." Contemporary Oncology/Współczesna Onkologia, vol. 16, no. 4, 2012, pp. 353-355. doi:10.5114/wo.2012.30068. Vancouver Świeboda-Sadlej A, Kraj L, Krawczyk J, Nita E, Dwilewicz-Trojaczek J. Thrombocytosis in Patients with Pancreatic Cancer Treated with Gemcitabine. Contemporary Oncology/Współczesna Onkologia. 2012;16(4):353-355. doi:10.5114/wo.2012.30068.
Referência(s)